Perth Biodesign

Digital Health

for

Innovate Using Transformative Technology

Analyse digital health challenges and learn how to apply Biodesign innovation process to research and evaluate unmet clinical needs, ideate solutions and make assessments against key criteria 

 

How It Works

  • Participants are placed in multidisciplinary teams and be assigned an alumni mentor to provide expert guidance 

  • The program operates for three months with in-person sessions delivered by course faculty and a variety of subject specialists one evening per week.

  • An overall time commitment of eight hours per week is estimated, inclusive of weekly sessions

  • However, initially, each team will spend at least ten hours in a clinical environment to identify unmet needs, with the support of a clinical mentor

  • Using the Biodesign innovation principals, each team will work towards inventing a digital solution and developing a viable business model

  • IP is 100% owned by the student team

 

What Is The Cost?

Student

$1250 inclusive of GST

With $500 refunded on course completion

Member*

$2000 inclusive of GST

With $500 refunded on course completion

General

$3000 inclusive of GST

With $500 refunded on course completion

* Members include any staff or members of our supporters 

Who Should Apply?

This course has been specifically designed for: 

  • Software developers and IT professionals

  • Healthcare professionals 

  • Business professionals

  • Postdoctoral, researchers and academic staff

However, we welcome all aspiring entrepreneurs and innovation staff with a passion for digital health 

DSC08804.jpg

What Is The Application Process?

  • Check your availability for the course & compulsory lead-up events 

  • Submit your online application, which includes submission of your CV and a short video 

  • If successful, you will be invited to an interview with the course directors to assess suitability 

  • If successful, you will be offered a position

 

Our Team

Simon Graindorge.jfif

Dr Simon Graindorge

Dr Simon Graindorge is the Chief Operating Officer at OncoRes Medical and also Entrepreneur in Residence at IP Group Australia. Simon has spent almost 20 years as an investor and operator in medical device and digital health companies in the UK.

 

He has extensive experience as both an operating executive and board director investing in, building and growing start-ups, early stage and emerging growth companies based on early-stage, deep technology innovations across healthcare. Before joining IP Group Australia as an Operating Partner, Simon was a Partner in the UK life sciences team at IP Group plc, leading investment strategy and portfolio in medtech and digital health/healthtech. Over the last decade he has invested in and helped build companies like Tissue Regenix Group plc, Oxehealth, Creavo Medical Technologies, Intelligent Ultrasound Group plc, Ibex Innovations, Pancregenesis.

 

Simon joined IP Group from Ceramex Ltd, a corporate spin-out of the Hexadex Group and was previously an Executive Director at Tissue Regenix Group plc. Simon holds a PhD in Biomedical Engineering from the University of Western Australia, and Bachelor degrees in both Mechanical Engineering and Chemistry, and is also a Chartered Engineer.

rmacliver.jpg

Richard Macliver

Richard is passionate about improving and innovating healthcare in Australia and globally. Currently, Richard acts as the Vice Chair for HISA WA (Australia's peak digital health body), as an advisory board member for Wise Realities and is committed to building the healthcare innovation ecosystem in WA. Richard has previously worked with Michael Mosley and other doctors in the area of developing sustainable healthcare to individuals/groups with diseases of lifestyle and at PwC Australia in healthcare consulting. 

Richard aims to change healthcare in Australia to a more patient focused system that rewards quality outcomes rather than fee for service. He also believes that technology, innovation and entrepreneurship will play a vital role in the continued improvement of the healthcare system.

michelle.jpg

Michelle Luca

Michelle was the Research Partnership and Engagement Manager at Cinglevue International, a research-led education technology solutions provider, responsible for advancing strategic research by enabling collaborative research initiatives with universities, research partners and stakeholders.

Michelle has 9+ years of experience in the Western Australian healthcare sector. She completed a Bachelor of Pharmacy at Curtin University in 2010 and has worked across many public hospitals as a senior clinical pharmacist. Michelle has also completed postgraduate qualifications in fitness, based on her strong personal interests in sport. Michelle’s board range of work experience allows her to provide new and innovative perspectives in research, engagement, innovation, promotion and educational technology.

Administered & Sponsored by

Perkins_Colour_Sml.jpg

Other Sponsors

Acknowledgement

Gov-WA-and-Network-logo.png

Perth Biodesign for Digital Health was initiated as a result of seed funding from the X-TEND WA program, New Industries Fund

The New Industries Fund is managed by the Department

of Jobs, Tourism, Science and Innovation

WADSIH-Logo.jpg
UWA logo.png